Anthropic & Morningstar DBRS

Anthropic: Anthropic is a rival AI firm that has signed a deal with SpaceX to rent computing capacity from its data centers. Anthropic is also preparing for its own IPO, contributing to a momentous year for Wall Street.

Morningstar DBRS: Morningstar DBRS>>> provided a contrarian valuation of SpaceX>>> at $780 billion, less than half of its target IPO valuation, citing concerns about its AI business and SpaceX — Starlink.

Anthropic: Anthropic faces competitive pressure from cheaper Chinese models and accusations that its models were used without authorization. US export controls on its models may inadvertently boost Chinese competitors.

Morningstar DBRS: Morningstar DBRS analyst Chelsey Tam commented on the competitive dynamics between US and Chinese AI ecosystems.

Anthropic: Anthropic is one of the AI heavyweights expected to follow SpaceX with an IPO, and its performance will be closely watched as a bellwether for investor appetite in the AI sector. SpaceX is also renting out its AI computing capacity to Anthropic.

Morningstar DBRS: Morningstar DBRS analysts expressed skepticism about SpaceX's valuation, calling it 'significantly overvalued' due to unproven technologies and capital needs.

Anthropic: Anthropic is a leading AI company planning an IPO, with a recent valuation of $965 billion and annualized revenue of $47 billion. Its rapid growth and IPO filing indicate strong market interest and potential for significant capital infusion.

Morningstar DBRS: Morningstar DBRS's chief equity analyst, Michael Field, provided an expert opinion on AI companies burning cash and using public equity as a source of capital.

Anthropic: Anthropic, a US AI company, may benefit from reduced Chinese competition, but the ban does not directly affect its operations.

Morningstar DBRS: Morningstar analysts commented on the ban's limited impact on China's overall development, providing analysis.

Anthropic: Anthropic signed a major compute rental agreement with SpaceX, contributing to SpaceX's AI revenue growth.

Morningstar DBRS: Morningstar estimates SpaceX's fair value at $63 per share, significantly below current trading levels, indicating overvaluation.

Morningstar DBRS: Morningstar DBRS analysts have expressed skepticism about SpaceX's valuation, deeming it 'significantly overvalued' due to unproven technologies and high capital needs. They provided a lower valuation estimate for the company.